- Healthcare Supply Chain Management Company Evaluation Report 2025 | SAP, Oracle, and IBM Lead with AI-Driven, Cloud-Based, and Analytics-Enhanced Solutions
Aug 19, 2025
Dublin, Aug. 19, 2025 (GLOBE NEWSWIRE) -- The "Healthcare Supply Chain Management - Company Evaluation Report, 2024" report has been added to ResearchAndMarkets.com's offering.
The Healthcare Supply Chain Management Companies Quadrant is a comprehensive industry analysis that provides valuable insights into the global market for Healthcare Supply Chain Management. This quadrant offers a detailed evaluation of key market players, technological advancements, product innovations, and emerging trends shaping the industry. The publisher's 360 Quadrants evaluated over 100 companies, of which the Top 19 Healthcare Supply Chain Management Companies were categorized and recognized as quadrant leaders.
Healthcare supply chain management involves acquiring, managing, and distributing medical supplies and services to both patients and healthcare providers. It focuses on creating efficient supply chain strategies within the healthcare sector to enhance operational efficiency and traceability, all while minimizing operating costs without compromising service quality.
The primary factors driving growth in the healthcare supply chain management market include growing pressure on healthcare providers to enhance operational efficiency; increasing demand for healthcare services due to rising population; a strong emphasis on reducing supply chain expenses; and the availability of funding, investments, and strategic partnerships. Nevertheless, the high costs associated with implementing advanced technologies and concerns about data privacy are expected to moderately hinder market expansion.
Key Players
Key players are actively investing in research and development, forming strategic partnerships, and engaging in collaborative initiatives to drive innovation, expand their global footprint, and maintain a competitive edge in this rapidly evolving market.
Top 3 Companies
SAP SE
SAP SE is a prominent player in the healthcare supply chain sector, known for its comprehensive suite of solutions designed to streamline healthcare logistics. SAP Integrated Business Planning and Product Lifecycle Management (PLM) Software are central to their offerings, facilitating seamless operations and enhancing supply chain visibility. They have made notable advancements in AI-driven supply chain solutions, aimed at improving efficiency and decision-making processes. SAP's significant geographical footprint spans North America, Europe, and emerging markets in the Asia-Pacific and Middle East regions. Their strategic focus on enhancing product portfolios through investments and partnerships underscores SAP's commitment to maintaining its leading role in the healthcare supply chain management market.
Oracle
Oracle leverages its technological prowess in the healthcare supply chain domain through solutions such as Oracle Supply Chain Planning Cloud and Oracle Inventory Management. These solutions are integral in managing complex supply chain demands and supporting healthcare providers in achieving greater transparency and efficiency. Oracle's reach extends globally, with operations in Europe, the Middle East, Africa, the Asia Pacific, and the Americas. Their continuous innovations in cloud-based solutions epitomize Oracle's strategic approach to maintaining a competitive edge. Collaborations and acquisitions further enhance their product portfolio and geographical presence, cementing their position as a market leader.
IBM
IBM offers a robust portfolio in supply chain management, prominently featuring the IBM Sterling Supply Chain Intelligence Suite. This suite leverages IBM's strengths in AI and analytics to optimize supply chain performance, crucial for reducing operational costs and enhancing service delivery. Their solutions serve a wide array of sectors, from healthcare to manufacturing, underscoring IBM's versatility and cross-industry expertise. With a strong presence across all major regions, IBM continues to influence the healthcare supply chain landscape through strategic alliances and continuous product innovation, facilitating improved market share and competitive positioning.
Key Topics Covered:
1 Introduction
1.1 Market Definition
1.2 Inclusions & Exclusions
1.3 Stakeholders
2 Executive Summary
3 Market Overview
3.1 Introduction
3.2 Market Dynamics
3.2.1 Drivers
3.2.1.1 Increasing Pressure on Healthcare Providers to Improve Operational Efficiency and Profitability
3.2.1.2 Rising Demand for Healthcare Services due to Population Growth and Aging Demographics
3.2.1.3 Focus on Reducing Supply Chain Costs
3.2.1.4 Demand for Transparency and Traceability
3.2.1.5 Availability of Funding, Investments, and Partnerships
3.2.1.6 Large-Scale Drug Counterfeiting in Pharmaceutical Industry
3.2.2 Restraints
3.2.2.1 High Implementation Costs for Advanced Technologies
3.2.2.2 Data Security and Privacy Concerns
3.2.2.3 Supply Chain Disruptions due to Global Events or Geopolitical Tensions
3.2.3 Opportunities
3.2.3.1 Increasing Use of Ai-Powered Solutions
3.2.3.2 Expansion into Emerging Markets with Growing Healthcare Demands
3.2.3.3 Expansion of E-Commerce in Healthcare
3.2.3.4 Enhanced Focus on Sustainability and Eco-Friendly Practices in Healthcare Logistics
3.2.4 Challenges
3.2.4.1 Complex and Varying Regulatory Requirements Across Regions
3.2.4.2 Shortage of Skilled Professionals to Manage Sophisticated Systems
3.3 Trends/Disruptions Impacting Customer's Business
3.4 Ecosystem Analysis
3.5 Value Chain Analysis
3.6 Technology Analysis
3.6.1 Key Technologies
3.6.1.1 Blockchain
3.6.1.2 Artificial Intelligence & Machine Learning
3.6.1.3 Cloud Computing
3.6.2 Complementary Technologies
3.6.2.1 Data Analytics
3.6.2.2 Internet of Things
3.6.3 Adjacent Technologies
3.6.3.1 Ar/Vr
3.7 Porter's Five Forces Analysis
3.7.1 Intensity of Competitive Rivalry
3.7.2 Bargaining Power of Buyers
3.7.3 Threat of Substitutes
3.7.4 Threat of New Entrants
3.7.5 Bargaining Power of Suppliers
3.8 Patent Analysis
3.8.1 Patent Publication Trends
3.8.2 Jurisdiction Analysis: Top Applicant Countries for Healthcare Supply Chain Management
3.8.3 Major Patents in Healthcare Supply Chain Management Market
3.9 Impact of Ai/Gen Ai on Healthcare Supply Chain Management Market
4 Competitive Landscape
4.1 Introduction
4.2 Key Player Strategy/Right to Win
4.2.1 Overview of Strategies Adopted by Key Players in Healthcare Supply Chain Management Market
4.3 Revenue Analysis, 2019-2023
4.4 Market Share Analysis, 2023
4.4.1 Ranking of Key Market Players
4.5 Company Evaluation Matrix: Key Players, 2023
4.5.1 Stars
4.5.2 Emerging Leaders
4.5.3 Pervasive Players
4.5.4 Participants
4.5.5 Company Footprint: Key Players, 2023
4.5.5.1 Company Footprint
4.5.5.2 Region Footprint
4.5.5.3 Offering Footprint
4.5.5.4 Function Footprint
4.5.5.5 End-User Footprint
4.6 Company Evaluation Matrix: Startups/Smes, 2023
4.6.1 Progressive Companies
4.6.2 Responsive Companies
4.6.3 Dynamic Companies
4.6.4 Starting Blocks
4.6.5 Competitive Benchmarking: Startups/Smes, 2023
4.7 Company Valuation & Financial Metrics
4.7.1 Financial Metrics
4.7.2 Company Valuation
4.8 Brand/Product Comparison
4.9 Competitive Scenario
4.9.1 Solution/Service Launches & Enhancements
4.9.2 Deals
4.9.3 Expansions
5 Company Profiles
Sap SeOracleIbmCardinal HealthInfor (Koch Industries)Manhattan AssociatesTecsys Inc.Global Healthcare Exchange, LLCEpicor Software CorporationCorcentric, Inc.Mckesson CorporationCoupaBlue Yonder Group, Inc. (Panasonic Corporation)Logitag SystemsPremierWorkday, Inc.Arvato Se (Bertelsmann Se & Co. KGaA)Cencora, Inc.GepJump Technologies, Inc.Medsphere Systems CorporationPromedeoProcurement PartnersVizient Inc.Inbeam TechnologiesConnectsx
For more information about this report visit https://www.researchandmarkets.com/r/hbl1a8
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Coupa Acquires Cirtuo to Add Category Management to Spend Management Platform
May 13, 2025 · pymnts.com
Coupa said Tuesday (May 13) that it has acquired Croatia-based Cirtuo to accelerate its roadmap for autonomous spend management. The acquisition adds Cirtuo's artificial intelligence (AI)-powered category management to Coupa's AI-native spend management platform, Coupa said in a Tuesday press release.
- EcoVadis' Coupa Connector Empowers Procurement Teams to Embed Sustainability into Every Purchasing Decision
Nov 21, 2024 · businesswire.com
PARIS & NEW YORK--(BUSINESS WIRE)--EcoVadis' Coupa Connector empowers procurement teams to embed sustainability into every purchasing decision.
- ECOVADIS' COUPA CONNECTOR EMPOWERS PROCUREMENT TEAMS TO EMBED SUSTAINABILITY INTO EVERY PURCHASING DECISION
Nov 21, 2024
PARIS & NEW YORK--(BUSINESS WIRE)--ECOVADIS' COUPA CONNECTOR EMPOWERS PROCUREMENT TEAMS TO EMBED SUSTAINABILITY INTO EVERY PURCHASING DECISION.
- CrossCountry Consulting Awarded Coupa's North America Regional Partner of the Year
Jun 4, 2024 · businesswire.com
MCLEAN, Va.--(BUSINESS WIRE)--CrossCountry Consulting, a leading business advisory firm, today announced they were awarded Coupa's North America Regional Partner of the Year at the third annual Coupa Partner Connect Awards. Coupa, the margin multiplier company, recognized CrossCountry based on their outstanding successes and dedication to Coupa. A partner since 2014, CrossCountry's more than 120 trained and certified Coupa consultants leverage operations and finance functional knowledge, intern.
- CROSSCOUNTRY CONSULTING AWARDED COUPA'S NORTH AMERICA REGIONAL PARTNER OF THE YEAR
Jun 4, 2024
MCLEAN, VA.--(BUSINESS WIRE)--CROSSCOUNTRY CONSULTING, A LEADING BUSINESS ADVISORY FIRM, TODAY ANNOUNCED THEY WERE AWARDED COUPA'S NORTH AMERICA REGIONAL PARTNER OF THE YEAR AT THE THIRD ANNUAL COUPA PARTNER CONNECT AWARDS. COUPA, THE MARGIN MULTIPLIER COMPANY, RECOGNIZED CROSSCOUNTRY BASED ON THEIR OUTSTANDING SUCCESSES AND DEDICATION TO COUPA. A PARTNER SINCE 2014, CROSSCOUNTRY'S MORE THAN 120 TRAINED AND CERTIFIED COUPA CONSULTANTS LEVERAGE OPERATIONS AND FINANCE FUNCTIONAL KNOWLEDGE, INTERN.
- Greg Harbor Joins Coupa as Chief Partner Officer
Apr 8, 2024 · prnewswire.com
Harbor brings three decades of experience to lead the company's global partner ecosystem strategy FOSTER CITY, Calif., April 8, 2024 /PRNewswire/ -- Coupa , the leading AI-driven platform that helps you operate smarter and grow faster, today announced Greg Harbor as its new Chief Partner Officer.
- GREG HARBOR JOINS COUPA AS CHIEF PARTNER OFFICER
Apr 8, 2024
HARBOR BRINGS THREE DECADES OF EXPERIENCE TO LEAD THE COMPANY'S GLOBAL PARTNER ECOSYSTEM STRATEGY FOSTER CITY, CALIF., APRIL 8, 2024 /PRNEWSWIRE/ -- COUPA , THE LEADING AI-DRIVEN PLATFORM THAT HELPS YOU OPERATE SMARTER AND GROW FASTER, TODAY ANNOUNCED GREG HARBOR AS ITS NEW CHIEF PARTNER OFFICER.
- 3 Robotics Stocks With 250% Growth Potential by 2025
Feb 1, 2024
As the human world hurtles into a future shaped by cutting-edge technologies, the robotics sector stands at the forefront of transformative growth. The article delves into the promising trajectories of three robotics stocks, each with the potential for a staggering 250% growth by 2025.
The first one’s focus on industry verticalization, with 70 tailored solution accelerators, positions it uniquely as a solution provider. On the other hand, the second one showcases robust growth in placements and utilization, coupled with strategic moves like the impending launch of a decisive product. Meanwhile, the third one navigates market challenges with a proactive cost restructuring approach and strategic collaborations, signaling resilience amid declining sales.
Read more to explore these three robotics stocks’ innovative strategies and growth prospects, each illuminating a distinct path toward solid growth potential.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
UiPath (PATH) A magnifying glass zooms in on the website homepage of UiPath (PATH).
Source: dennizn / Shutterstock.com
UiPath’s (NYSE:PATH) focus on industry verticalization as a strategic priority may serve as a vital fundamental. The availability of 70 solution accelerators in the marketplace tailored to specific industries showcases UiPath’s focus on capitalizing on unique challenges faced by organizations in various domains.
Fundamentally, this industry-focused approach broadens UiPath’s market reach. Also, it positions the company as a solution provider rather than a one-size-fits-all automation platform. This is particularly crucial in industries with specific regulatory requirements, where a tailored solution can deliver more significant value. The number and popularity of downloads for accelerators such as IT Service Management Software user provisioning and two-way match invoice processing for Coupa (NASDAQ:COUP) and SAP (NYSE:SAP) indicate a strong market demand for industry-specific solutions.
Furthermore, UiPath’s collaboration with SAP and strategic partnerships with companies like The Arnott’s Group suggests the company’s lead in expanding its reach through synergistic relationships. The strategic integration with SAP enables UiPath to tap into SAP’s customer base and offer complementary automation solutions. Also, the selection of UiPath by The Arnott’s Group (an Australian giant in biscuit and snack food) to optimize business processes and reduce operating costs demonstrates the practical value of UiPath solutions.
Story continues
This opens new revenue streams by enhancing UiPath’s credibility and market positioning. The expanded partnership with Deloitte further strengthens UiPath’s presence in the SAP ecosystem. In detail, Deloitte embeds UiPath’s AI-powered Business Automation Platform into its service delivery platform. At a broader level, UiPath’s FX-adjusted dollar-based net retention rate of 123% suggests it leads to expanding revenue from existing customers.
Intuitive Surgical (ISRG) A sign with the Intuitive Surgical logo standing outside of a company office. ISRG stock.
Source: Sundry Photography / Shutterstock.com
To begin with the capital front, IntuitiveSurgical (NASDAQ:ISRG) placed 1,313 multi-port systems in 2023, reflecting decisive growth from 2022. Ion placements increased from 192 to 213, and SP placements grew from 23 to 57 for the full year. Placements were strong in the United States and Japan. The use of flexible financing arrangements, especially in the U.S., played a significant role in supporting the expansion of DaVinci system portfolios.
In 2023, system utilization (procedures per installed clinical system per quarter) grew globally, reaching a new high for the multi-port platform. Utilization is crucial to patient demand, care team satisfaction, and hospital financial health. At the top line, the revenue marked 14% year-over-year growth.
Fundamentally, capital and operating expenses were on the upper end of the guidance. This reflects continued investments in R&D, expansion of manufacturing and commercial footprints, and capital amortization. Critically, there is demand strength in procedures, growth in the clinical install base, and increased utilization. Hence, this suggests continued preference by customers for Intuitive’s platforms.
Looking ahead to 2024, the company has submitted its 510(k) application for its next-generation multi-port platform, DaVinci 5. The design priorities for DaVinci 5 include bringing better minimally invasive care to more patients. The design may improve platform performance, enhance care team satisfaction, and lower the total treatment cost per patient episode. Thus, the phased launch plan post-Food and Drug Administration (FDA) clearance suggests the company’s supply and manufacturing readiness.
Lastly, conversations with regulators in Japan and Korea have been initiated. This further boosts the company’s top line (based on regulatory outcomes) through progress toward commercialization in countries outside the U.S. This is easily one of the top robotics stocks out there.
Zebra (ZBRA) A photo of the sign for Zebra Technologies (ZBRA) outside of a building.
Source: Michael Vi/ShutterStock.com
Zebra (NASDAQ:ZBRA) focuses explicitly on cost restructuring and net annualized savings. The company implemented significant cost restructuring actions in late Q3 and early Q4. These actions are expected to yield net annualized cost savings of $100 million, surpassing the initial expectation of $85 million. This demonstrates Zebra’s proactive approach to optimizing its cost structure for improved profitability.
Despite the overall decline in sales (30% decline), services and software emerged as bright spots in the quarter. The diversification across products and services helps Zebra mitigate the impact of declines in specific product categories. Also, Zebra is reallocating resources to accelerate growth in underpenetrated markets, including Japan, government, and manufacturing sectors.
Additionally, there are collaborations with partners like Qualcomm (NASDAQ:QCOM). These are to demonstrate generative AI without cloud connectivity, reflecting Zebra’s focus on staying at the edge. Further, there are multiple wins with global technology providers, large healthcare systems, retail pharmacy chains, and North American retailers. These wins highlight Zebra’s solutions’ continued relevance and importance across various industries.
Financially, there was a negative free cash flow of $193 million for Q1–Q3 2023. However, the reasons behind this negative cash flow include higher interest costs, restructuring actions, and settlement payments. These issues are temporary and may not impact Zebra’s liquidity in the long term.
Finally, the 2.2x net debt to adjusted EBITDA leverage ratio with the availability of approximately $1 billion of capacity on a revolving credit facility demonstrates Zebra’s financial flexibility. Therefore, these developments may support Zebra’s value growth in the upcoming years. If you are looking for some top robotics stocks, you should take a look at this one.
On the date of publication, Yiannis Zourmpanos did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
Yiannis Zourmpanos is the founder of Yiazou Capital Research, a stock-market research platform designed to elevate the due diligence process through in-depth business analysis.
More From InvestorPlace
ChatGPT IPO Could Shock the World, Make This Move Before the Announcement Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
The post 3 Robotics Stocks With 250% Growth Potential by 2025 appeared first on InvestorPlace.
- The Next Big Thing: 3 Tech Stocks Ready for a 500% Leap by 2027
Dec 29, 2023
In an era where technological advancements wield unprecedented influence, the hunt for the following game-changing tech stocks intensifies. Imagine a landscape where three tech juggernauts illuminate the path to a staggering 5X surge by 2027. Operating at the forefront of semiconductor materials, systems, and application software, these companies aren’t just names on a stock ticker; they’re heralds of a transformative wave in the market.
The article dissects the fundamentals of resilience, innovation, and strategic brilliance fueling these tech giants’ meteoric rise. The first defies industry downturns; the second revolutionizes automation solutions; and the third orchestrates strategic alliances in 5G innovation. This article isn’t merely about tech stocks. It’s an odyssey through the convergence of technological prowess, strategic foresight, and exponential growth.
Tech Stocks: Photronics (PLAB) PLAB stock: Electronic board, pen, processor on the background of schematic circuit diagram and photomask for manufacture of printed circuit boards.
Source: Mentor57 / Shutterstock
Photonics‘ (NASDAQ:PLAB) attainment of a CAGR of over 12% for the past six years signifies its ability to expand its revenue base consistently. This sustained growth rate highlights the company’s successful strategies, market positioning, and adaptability while capitalizing on demand.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Despite the photomask market remaining flat and the broader semiconductor industry facing an expected contraction of up to 12% in 2023, Photronics managed an impressive 8% year-over-year (YOY) revenue growth. This outperformance against industry expectations demonstrates the company’s resilience and potential to capture market share even during challenging periods.
Specifically, Photronics’ IC revenue in Q4 2023 reached $164.5 million, growing 1% sequentially and 5% YOY. The significant 27% sequential growth in high-end revenue from IC masks using 28-nanometer and smaller technology was a driving force behind this growth. Also, the company’s ability to capitalize on high-end demand in foundry logic both in the U.S. and Asia showcases its technological prowess and market adaptability.
Story continues
In the same context, Q4 Flat Panel Displays (FPD) revenue hit a record $63 million, showing a 3% sequential increase and a substantial 17% YOY growth. The 7% increase in high-end revenue, particularly from AMOLED display masks used in mobile displays, demonstrates Photronics’ technological leadership and strong market position in high-growth segments like mobile display technologies.
Moving to CapEx, Photronics’ continued investment in high-return projects has been a key driver behind its consistent growth over the past several years. The company plans to invest $140 million in CapEx for 2024, focusing primarily on expanding high-end and mainstream IC capacity.
Finally, acquiring a new multi-beam lithography tool for leading-edge development in fiscal year 2025 emphasizes Photronics’ commitment to technological advancement and value growth.
UiPath (PATH) A magnifying glass zooms in on the website homepage of UiPath (PATH).
Source: dennizn / Shutterstock.com
UiPath’s (NYSE:PATH) ability to expand its customer base while retaining existing clients is a key driver of its growth potential. In Q3 fiscal 2024, UiPath closed a record number of deals over $1 million in annual recurring revenue (ARR) and witnessed growth in customers with $1 million or more in ARR by 31% to 264.
Fundamentally, closing a record number of deals over $1 million in ARR indicates UiPath’s success in acquiring high-value customers. These large deals contribute significantly to immediate revenue and represent the company’s ability to cater to the needs of larger enterprises seeking extensive automation solutions. A 31% increase in such customers signifies their satisfaction with UiPath’s offerings, leading to upselling or increased adoption of the company’s solutions.
Regarding industry verticalization, there are 70 solution accelerators in the marketplace. This magnitude highlights UiPath’s focus on providing tailored solutions for various industries. Solution accelerators address specific industry pain points, such as IT Service Management Software and two-way match invoice processing for Coupa (NASDAQ:COUP) and SAP (NYSE:SAP).
Additionally, UiPath’s success stories with federal agencies like the United States Department of Agriculture, Veterans Affairs, Coast Guard, IRS, and Department of Homeland Security demonstrate the platform’s adaptability to government and public sector needs.
On the other hand, UiPath’s collaboration with Deloitte, Amazon (NASDAQ:AMZN), Bedrock, and the upcoming availability on the Google (NASDAQ:GOOG, NASDAQ:GOOGL) Cloud Marketplace exemplify its strategic alliances. These partnerships facilitate deeper market penetration, product integrations, and increased accessibility to UiPath’s AI-powered Business Automation Platform.
Overall, the engagement with more than 750 partners at Forward VI emphasizes UiPath’s commitment to expanding its ecosystem. Therefore, such collaborations increase engagement with global systems integrators and expand market reach.
InterDigital (IDCC) A hexagonal grid with different tech-related icons; Tech stocks illustration. Best Tech stocks
Source: whiteMocca / Shutterstock
InterDigital’s (NASDAQ:IDCC) strategic partnerships and licensing agreements are pivotal in shaping its growth trajectory, emphasizing technological advancements and market expansion. For instance, a strategic milestone is the multi-year royalty-bearing license with Lenovo (OTCPK:LNVGY) covering High-Efficiency Video Coding (HEVC) video compression technology for smartphones and consumer electronics.
Similarly, the license agreement with Humax for set-top boxes signifies IDCC’s diversified portfolio and strong market presence in video-related technologies beyond smartphones and consumer electronics. These agreements validate IDCC’s position as a key player in providing essential technologies across various devices, consolidating its leadership in the market.
Moreover, IDCC’s involvement as a founding member of the Avanci 5G automobile patent licensing platform marks its strategic foresight in solidifying opportunities in the automotive sector. The licensing of 5G technology to renowned automobile manufacturers such as Mercedes-Benz (OTCPK:MBGAF) and BMW (OTCPK:BMWYY) suggests a promising revenue stream and underscores IDCC’s positioning in high-value sectors.
Fundamentally, the company’s anticipation of increased revenue from connected cars due to growing 5G adoption aligns with the rapid evolution of connectivity in the automotive industry. This forward-looking approach to capitalizing on the rising significance of 5G in automobile manufacturing augurs well for IDCC’s revenue growth prospects in this domain.
Finally, the significance of InterDigital’s patent portfolio, exceeding 30K granted patents and pending applications, solidifies the company’s position as a leading innovator in wireless and video technologies. Hence, this extensive patent portfolio quantifies and represents the quality and depth of IDCC’s intellectual property assets and makes it one of those tech stocks to own.
On the date of publication, Yiannis Zourmpanos did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
More From InvestorPlace
The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
The post The Next Big Thing: 3 Tech Stocks Ready for a 500% Leap by 2027 appeared first on InvestorPlace.
